Tangential flow filtration in tetanus vaccine production may serve as a model for other vaccine production systems.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Prado, S.M.A., Vancetto, M.D.C., Fratelli, F., et al. 1992. Industrial purification of tetanus toxoid by gel filtration. Bol. Biotecnol. 3: 11–16.
Prado, S.M.A., Vancetto, M.D.C., de Oliveira, J.M., et al. 1993. Optimization of the tetanus toxoid industrial purification process by gel filtration. Bol. Biotecnol. 4: 3–8.
Raynaud, M., Bizzini, B., and Turpin, A. 1971. Heterogeneity of tetanus anatoxin. Ann. Inst. Pasteur. 120: 801–815.
World Health Organization. 1977. Manual for the production and control of vaccines: tetanus toxoids. World Health Organization, Geneva.
Fratelli, F, Prado, S.M A, Vancetto, M.D.C., et al. 1993. Tetanus toxin: Industrial-scale production and purification. Arq. Biol. Technol. 36: 709–719.
Vancetto, M.D.C., de Oliveira, J.M., Prado, S.M.A, et al. 1994.Tetanus anatoxin purification by tangential flow filtration.Arq. Biol. Technol. 37: 577–586.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vancetto, M., de Oliveira, J., Prado, S. et al. Tetanus toxoid purification: A case study. Nat Biotechnol 15, 807–808 (1997). https://doi.org/10.1038/nbt0897-807
Issue Date:
DOI: https://doi.org/10.1038/nbt0897-807